Individualised Homoeopathic Treatment of Chronic Brucellosis in human beings along with Standard Care

Phase 2

• Conditions: Health Condition 1: A231- Brucellosis due to Brucella abortusHealth Condition 2: A233- Brucellosis due to Brucella canisHealth Condition 3: A230- Brucellosis due to Brucella melitensisHealth Condition 4: A232- Brucellosis due to Brucella suisHealth Condition 5: A239- Brucellosis, unspecifiedHealth Condition 6: A238- Other brucellosis

• Registration Number: CTRI/2024/03/063640
• Lead Sponsor: Central Council for Research in Homoeopathy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

•Patients aged between 18 and 60 present with clinical signs and symptoms of recurrent or chronic Brucellosis. (Chronic brucellosis refers to patients whose symptoms persist for 12 months or more from diagnosis and treatment ).

•Patients willing to give informed consent.

Exclusion Criteria

•Known cases of uncontrolled diabetes hypertension.

•Person with any organic changes CA and others, i.e. tuberculosis, etc.

•Severe condition of the patient in any aspect of health.

•Pregnant or lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
symptomatic profile of the pateint will be assessed by cured,major improvemnt,moderate improvement,slight improvement,no changes,slight detioration,moderate detioration ,major detioration and diststrous detioration.MYMOP 2 tool to find the improvemnt.Timepoint: base line, Every 03 day for first 1 month(09 times),consecutively per month for next 11 months. <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
To assess the Quality of Life (QoL) using the EQ-5D-5L questionnaire as a parameter to compare and detect differences between two groups. This evaluation will provide valuable insights into the impact of the treatment approach on the overall well-being and quality of life of patients in each group.Timepoint: To assess the Quality of Life (QoL) using the EQ-5D-5L questionnaire EVERY MONTH, UPTO 12 TH MONTH. <br/ ><br>Using MYMOP Questionnaire every month upto 12th month. <br/ ><br>Modified Naranjo criteria every month upto 12th month